Mouse studies All in vivo experiments were conducted according to international principles of animal care and under the approval of the Danish Ethical Committee for Animal Research and the Danish Animal Experimentation Inspectorate
Choose tirzepatide if you need mature Phase 3 safety data, a confirmed regulatory pathway, simpler titration, or a comparator with established cardiovascular outcome signals
Estimated turnaround for results is 8 business days
Michael Koehler, MD , takes a comprehensive approach, monitoring your progress, adjusting dosing, and addressing the full picture of metabolic health

Contact your healthcare provider if you experience: Hot flashes accompanied by chest pain, palpitations, or irregular heartbeat Severe or persistent flushing with associated shortness of breath or dizziness Hot flashes that significantly interfere with daily activities or sleep quality New or worsening symptoms despite lifestyle modifications Severe, persistent abdominal pain (especially radiating to the back) with or without vomiting Yellowing of skin/eyes (jaundice), pale stools, or dark urine Signs of allergic reaction including facial/lip swelling, rash, hives, or difficulty breathing Signs of thyroid dysfunction including tremor, anxiety, or changes in bowel habits Concurrent symptoms such as excessive sweating, fever, or night sweats If you're taking tirzepatide with insulin or sulfonylureas, check your blood glucose during episodes that resemble hot flashes, as hypoglycemia can cause similar symptoms